about
Immunohistochemical expression of insulin-like growth factor binding protein-3 in invasive breast cancers and ductal carcinoma in situ: implications for clinicopathology and patient outcome.Differential regulation of somatostatin receptors 1 and 2 mRNA and protein expression by tamoxifen and estradiol in breast cancer cellsFunctional roles and clinical values of insulin-like growth factor-binding protein-5 in different types of cancersThe integrative role of leptin, oestrogen and the insulin family in obesity-associated breast cancer: potential effects of exercisemTOR Directs Breast Morphogenesis through the PKC-alpha-Rac1 Signaling AxisIs there a role for IGF-1 in the development of second primary cancers?Active stromelysin-3 (MMP-11) increases MCF-7 survival in three-dimensional Matrigel culture via activation of p42/p44 MAP-kinaseWnt pathway is involved in pleomorphic adenomas induced by overexpression of PLAG1 in transgenic miceMetabolic syndrome and breast cancer risk: a case-cohort study nested in a multicentre italian cohortAlternatively activated macrophages and collagen remodeling characterize the postpartum involuting mammary gland across speciesCrosstalk between the p190-B RhoGAP and IGF signaling pathways is required for embryonic mammary bud developmentAging and the Mammalian regulatory triumvirateTargeting Insulin Receptor with a Novel Internalizing AptamerMolecular mechanisms and treatment of bone metastasis.Identification of bioactive molecules by adipogenesis profiling of organic compounds.IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).IGF-I induced genes in stromal fibroblasts predict the clinical outcome of breast and lung cancer patients.IGF-I regulates redox status in breast cancer cells by activating the amino acid transport molecule xC-.Insulin-like growth factor I controls adhesion strength mediated by alpha5beta1 integrins in motile carcinoma cells.Association between insulin resistance and breast carcinoma: a systematic review and meta-analysis.Co-targeting the IGF system and HIF-1 inhibits migration and invasion by (triple-negative) breast cancer cells.Inhibition of cancer cell proliferation and metastasis by insulin receptor downregulationCollagen density promotes mammary tumor initiation and progressionMagnetic resonance in the detection of breast cancers of different histological types.Expression Profiles of the Insulin-like Growth Factor System Components in Liver Tissue during Embryonic and Postnatal Growth of Erhualian and Yorkshire Reciprocal Cross F1 Pigs.Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy.Mammary gland growth factors: roles in normal development and in cancer.The mitogenic action of insulin-like growth factor I in normal human mammary epithelial cells requires the epidermal growth factor receptor tyrosine kinase.Insulin-like growth factor-1 signaling regulates miRNA expression in MCF-7 breast cancer cell line.Role of inflammation and oxidative stress in post-menopausal oestrogen-dependent breast cancer.Type I insulin-like growth factor receptor over-expression induces proliferation and anti-apoptotic signaling in a three-dimensional culture model of breast epithelial cellsIGF-1 increases invasive potential of MCF 7 breast cancer cells and induces activation of latent TGF-β1 resulting in epithelial to mesenchymal transition.The R-Ras GTPase mediates cross talk between estrogen and insulin signaling in breast cancer cells.The role of the insulin-like growth factor-1 system in breast cancerDiabetes, diabetes treatment and breast cancer prognosis.Genetic variation in IGFBP2 and IGFBP5 is associated with breast cancer in populations of African descent.Reduced mitogenicity of sera following weight loss in premenopausal women.Growth factor receptors as therapeutic targets: strategies to inhibit the insulin-like growth factor I receptor.Expression of insulin receptor substrate 1 in primary breast cancer and lymph node metastases.Evaluation of the synergistic effect of insulin resistance and insulin-like growth factors on the risk of breast carcinoma
P2860
Q24796824-4DE4A017-ABE6-4860-A5C6-D126133341C6Q24812181-EEC2D318-7861-4E55-90AB-D54AA2A61682Q26830002-1864380C-64A5-4A4F-8AB7-A3C08B4F9C4CQ26861527-08C34AE8-3FE1-4081-9D3C-A63CB958F16DQ27310985-AFF4FDD1-3C88-4E34-BFC8-682A9A1571A0Q28069262-C3DF5D96-AA47-44EF-AFA7-D76FFAA33EDCQ28185337-2B2D1310-A7C6-4F34-91E4-0CA0E175CF0EQ28267847-AC6B32FE-41B2-4184-BB2D-2862C2BF5D3EQ28395376-BEC4021C-E7E5-4EE8-8561-A36627A81783Q28576808-4644C133-798C-4377-A047-0A02A86E8D9FQ28587428-4B2645E6-B538-4067-BE83-360FDD207F54Q28731496-37951A13-E771-420C-BA32-2C33542100FAQ28822291-95E84C38-6E9A-4A7D-836F-3C625C5A57DAQ30445717-5CC7326E-06CD-4C7D-B03E-165D2242C5C4Q30877450-92187E30-022A-42CF-969B-2864E400B114Q33348545-729FCE24-3E79-430D-A4BE-757ED48F5913Q33522034-4B697D9D-ADC3-4225-AEF2-0FF7D01928C3Q33551399-75CB084A-5496-4157-864E-911A95F1FF1EQ33564187-B663AAC1-8BCB-4FA5-9063-E7B5C2176232Q33727819-F3905BF2-F0A0-4E28-983A-A533236F9882Q33750192-43D31681-D889-453D-BD0C-A3A78D955907Q33818935-3B34B3AE-E327-4D33-949C-87185D54D543Q33845553-82F26DC5-501A-4A6D-9F10-7C891723698DQ33873362-7119B44A-CB58-4198-BDDD-8AB449CD05F1Q33884308-CA66D4B9-B7B1-470C-9767-1E9CFE53CC2AQ33934670-3EC239F3-AF78-4772-9C72-3EE3F8EE2534Q34014659-A14FABBC-10D1-46D5-B9C6-BFE5DCA30E2CQ34273711-CF0DDA71-E5A7-4647-AC31-CC81EA136612Q34504974-E11EF2C6-2EA5-407D-9D0D-7508B6CD90B2Q34998410-DBA601CC-F197-41A3-B20D-E53EF42A0D91Q35012773-1CBEA37A-B005-45E8-A688-ABA1A037521AQ35014600-4C836C75-B9B8-48EB-A065-7D21F7EABA62Q35071166-752435F2-6510-4875-8B1B-48CA34918C2DQ35105295-F8582F66-6905-4D1B-8C45-0AD784D1E80BQ35373602-9D81EAF8-6E11-4C9B-93FD-D7AF097CF60FQ35524233-AB9959C0-28BA-4046-A91F-E1B8F144B3F7Q35532543-515E4ECF-4767-4216-BFED-19156F1F52FCQ35551142-7BCB67A4-DD15-4820-9D74-069340812C6CQ35588605-E23E80E6-4597-4408-B24C-A886F86C0556Q35607521-6E6C8598-749F-4D4D-B05A-83F16964758B
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The IGF system and breast cancer.
@ast
The IGF system and breast cancer.
@en
The IGF system and breast cancer.
@nl
type
label
The IGF system and breast cancer.
@ast
The IGF system and breast cancer.
@en
The IGF system and breast cancer.
@nl
prefLabel
The IGF system and breast cancer.
@ast
The IGF system and breast cancer.
@en
The IGF system and breast cancer.
@nl
P356
P1476
The IGF system and breast cancer.
@en
P304
P356
10.1677/ERC.0.0080197
P577
2001-09-01T00:00:00Z